Cargando…

Novel Influenza Vaccines: From Research and Development (R&D) Challenges to Regulatory Responses

Influenza vaccines faced significant challenges in achieving sufficient protective efficacy and production efficiency in the past. In recent decades, novel influenza vaccines, characterized by efficient and scalable production, advanced platforms, and new adjuvant technologies, have overcome some of...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Xiangchuan, Zhang, Tianxiang, Huan, Shitong, Yang, Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610648/ https://www.ncbi.nlm.nih.gov/pubmed/37896976 http://dx.doi.org/10.3390/vaccines11101573

Ejemplares similares

Prospects and Challenges in the Development of Universal Influenza Vaccines
por: Madsen, Anders, et al.
Publicado: (2020)

Research Updates for Influenza Virus and Vaccine Development
por: Plant, Ewan P., et al.
Publicado: (2021)

Challenges in the development of T-cell–based universal influenza vaccines
por: Kang, Jung-Ok, et al.
Publicado: (2017)

Computational Approaches and Challenges to Developing Universal Influenza Vaccines
por: Qiu, Xueting, et al.
Publicado: (2019)

Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities
por: Amorij, J-P., et al.
Publicado: (2008)

Pandemic Influenza Vaccines – The Challenges
por: Haaheim, Lars R., et al.
Publicado: (2009)

Novel coronavirus mutations: Vaccine development and challenges
por: Luo, Wan-Rong, et al.
Publicado: (2022)

Challenges in the research and development of new human vaccines
por: Barbosa, T., et al.
Publicado: (2013)

Influenza Vaccines: Successes and Continuing Challenges
por: Becker, Tanja, et al.
Publicado: (2021)

Novel Platforms for the Development of a Universal Influenza Vaccine
por: Kumar, Arun, et al.
Publicado: (2018)

Novel Approaches for The Development of Live Attenuated Influenza Vaccines
por: Blanco-Lobo, Pilar, et al.
Publicado: (2019)

Current status of vaccine research, development, and challenges of vaccines for Mycoplasma gallisepticum
por: Ishfaq, Muhammad, et al.
Publicado: (2020)

Vaccines: Biotechnology Market, Coverage, and Regulatory Challenges for Achieving Sustainable Development Goals
por: Possas, Cristina, et al.
Publicado: (2019)

Dietary Supplements: Regulatory Challenges and Research Resources
por: Dwyer, Johanna T., et al.
Publicado: (2018)

R and D: essays on the economics of research and development
por: Hamberg, Daniel
Publicado: (1966)

A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice
por: Cao, Kangli, et al.
Publicado: (2022)

Vaccines for an influenza pandemic: scientific and political challenges
por: Haaheim, Lars R.
Publicado: (2007)

Next-generation influenza vaccines: opportunities and challenges
por: Wei, Chih-Jen, et al.
Publicado: (2020)

Development of novel cationic microemulsion as parenteral adjuvant for influenza vaccine
por: Lamaisakul, Sakalanunt, et al.
Publicado: (2020)

Vaccine Preparedness for the Next Influenza Pandemic: A Regulatory Perspective
por: Baylor, Norman W., et al.
Publicado: (2022)

Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs
por: Hare, Jonathan, et al.
Publicado: (2023)

Influenza and Universal Vaccine Research in China
por: Li, Jiali, et al.
Publicado: (2022)

A Regulatory Circuit Orchestrated by Novel-miR-3880 Modulates Mammary Gland Development
por: Zhang, Yue, et al.
Publicado: (2020)

From Monovalent to Multivalent Vaccines, the Exploration for Potential Preventive Strategies Against Hand, Foot, and Mouth Disease (HFMD)
por: He, Xiangchuan, et al.
Publicado: (2020)

Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacity
por: Innis, Bruce L., et al.
Publicado: (2019)

Incorporating Research and Evaluation into Pandemic Influenza Vaccination Preparedness and Response
por: Shimabukuro, Tom T., et al.
Publicado: (2014)

Examination of Influenza Specific T Cell Responses after Influenza Virus Challenge in Individuals Vaccinated with MVA-NP+M1 Vaccine
por: Powell, Timothy J., et al.
Publicado: (2013)

Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines
por: Sridhar, Saranya
Publicado: (2016)

Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine
por: Wright, Peter F., et al.
Publicado: (2016)

Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challenges
por: Lee, Andrew Chak-Yiu, et al.
Publicado: (2021)

Development of a novel equine influenza virus live-attenuated vaccine
por: Rodriguez, Laura, et al.
Publicado: (2018)

Experience and challenges on influenza and pertussis vaccination in pregnant women
por: Madhi, Shabir A., et al.
Publicado: (2018)

A Retrospective Study of Patients with GABA(B)R Encephalitis: Therapy, Disease Activity and Prognostic Factors
por: Wen, Xiangchuan, et al.
Publicado: (2021)

The Role of Animal Models In Influenza Vaccine Research
por: Luke, Catherine J., et al.
Publicado: (2010)

The role of animal models in influenza vaccine research
por: Luke, Catherine J., et al.
Publicado: (2008)

Enhanced humoral response to influenza vaccine in aged mice with a novel adjuvant, rOv-ASP-1
por: Jiang, Jiu, et al.
Publicado: (2016)

A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy
por: Moore, Kristine A., et al.
Publicado: (2023)

Regulatory network characterization in development: challenges and opportunities
por: Peng, Guangdun, et al.
Publicado: (2018)

Host immune response–inspired development of the influenza vaccine
por: Choi, Angela, et al.
Publicado: (2020)

Development of novel vaccine candidates and challenge models for Plasmodium vivax
por: Alves, Eduardo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3pdvishe0egn2tq0elg55ls0d2